Cost effectiveness of tibial nonunion treatment: A comparison between rhBMP-7 and autologous bone graft in two Italian centres

Injury

Volumn 44, Issue 12, 2013, Pages 1871-1879

  Maria, Calori Giorgio ^a   Rodolfo, Capanna ^b   Massimiliano, Colombo ^a   Pietro, De Biase ^b   Carol, O'Sullivan ^d   Valentina, Cartareggia ^c   Costanza, Conti ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c Sanipedia Srl   (Italy)

^d Olympus Biotech International   (Ireland)

Author keywords

Adverse events; Cost effectiveness; Cost utility; Costs; Eptotermin alfa; Italy; OP 1; Osteogenic protein 1; rhBMP 7; Tibial nonunions

Indexed keywords

RECOMBINANT OSTEOGENIC PROTEIN 1; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT PROTEIN;

ADULT; ARTICLE; BONE GRAFT; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; ITALY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; PSEUDARTHROSIS; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT; TIBIA; BONE TRANSPLANTATION; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FOLLOW UP; FRACTURE HEALING; FRACTURES, UNUNITED; HEALTH CARE COST; HOSPITAL READMISSION; INTRAMEDULLARY NAILING; LENGTH OF STAY; MULTICENTER STUDY; PROCEDURES; RETROSPECTIVE STUDY; TIBIAL FRACTURES; TREATMENT OUTCOME;

BONE MORPHOGENETIC PROTEIN 2; BONE TRANSPLANTATION; CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; FRACTURE FIXATION, INTRAMEDULLARY; FRACTURE HEALING; FRACTURES, UNUNITED; HEALTH CARE COSTS; HUMANS; ITALY; LENGTH OF STAY; MALE; PATIENT READMISSION; QUALITY-ADJUSTED LIFE YEARS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TIBIAL FRACTURES; TREATMENT OUTCOME;

EID: 84887126667     PISSN: 00201383     EISSN: 18790267     Source Type: Journal    
DOI: 10.1016/j.injury.2013.08.012     Document Type: Article

References (24)

1. N.K. Kanakaris, G.M. Calori, and R. Verdonk Application of BMP-7 to tibial non-unions: a 3-year multicenter experience Injury 39 Suppl. 2 2008 S83 S90
2. G.E. Friedlaender, C.R. Perry, and J.D. Cole Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions J Bone Joint Surg Am 83-A Suppl. 1 (Pt 2) 2001 S151 S158
3. L.S. Phieffer, and J.A. Goulet Delayed unions of the tibia J Bone Joint Surg Am 88 1 2006 206 216
4. R. Beaver, M.R. Brinker, and R.L. Barrack An analysis of the actual cost of tibial nonunions J La State Med Soc 149 6 1997 200 206
5. J.D. Heckman, and J. Sarasohn-Kahn The economics of treating tibia fractures. The cost of delayed unions Bull Hosp Jt Dis 56 1 1997 63 72
6. N.K. Kanakaris, and P.V. Giannoudis The health economics of the treatment of long-bone non-unions Injury 38 Suppl. 2 2007 S77 S84
7. J.A. Goulet, L.E. Senunas, G.L. DeSilva, and M.L. Greenfield Autogenous iliac crest bone graft. Complications and functional assessment Clin Orthop Relat Res 339 1997 76 81
8. T.A. St John, A.R. Vaccaro, and A.P. Sah Physical and monetary costs associated with autogenous bone graft harvesting Am J Orthop (Belle Mead, NJ) 32 1 2003 18 23
9. W. Palmer, A. Crawford-Sykes, and R.E. Rose Donor site morbidity following iliac crest bone graft West Indian Med J 57 5 2008 490 492
10. K.R. Garrison, S. Donell, and J. Ryder Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review Health Technol Assess 11 30 2007 1 150 iii-iv
11. K.R. Garrison, I. Shemilt, and S. Donell Bone morphogenetic protein (BMP) for fracture healing in adults Cochrane Database Syst Rev 6 2010 CD006950
12. G.M. Calori, L. Tagliabue, and L. Gala Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients Injury 39 12 2008 1391 1402
13. Z. Dahabreh, R. Dimitriou, and P.V. Giannoudis Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7 Injury 38 3 2007 371 377
14. Z. Dahabreh, G.M. Calori, and N.K. Kanakaris A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7 Int Orthop 33 5 2009 1407 1414
15. A.G. Vinken, A. van Engen, J. Albert, T. Gosling, M. van Griensven, C. Krettek, and G. Andrew The cost-effectiveness of OSIGRAFT (Osteogenic Protein-1) in the treatment of tibial Non-unions in the UK and Germany 6th EFORT Congress (June 2003); Helsinki Finland - POSTER 2003
16. P. Dolan, and C. Gudex Time preference, duration and health state valuations J Health Econ 4 4 1995 289 299
17. M. James, S. St Leger, and K.V. Rowsell Prioritising elective care: a cost utility analysis of orthopaedics in the north west of England J Epidemiol Commun Health 50 2 1996 182 189
18. G.M. Calori, W. Albisetti, and A. Agus Risk factors contributing to fracture non-unions Injury 38 Suppl. 2 2007 S11 S18
19. G.M. Calori, M. Phillips, and S. Jeetle Classification of non-union: need for a new scoring system? Injury 39 Suppl. 2 2008 S59 S63
20. L. Prieto, and J.A. Sacristan Problems and solutions in calculating quality-adjusted life years (QALYs) Health Qual Life Outcomes 1 2003 80
21. K.J. Bozic, A.G. Rosenberg, R.S. Huckman, and J.H. Herndon Economic evaluation in orthopaedics J Bone Joint Surg Am 85-A 1 2003 129 142
22. M.F.S.M. Drummond, G.W. Torrace, B.J. O'Brien, and G.L. Stoddart Methods for the economic evaluation of health care programmes 3rd ed. 2005 Oxford University Press
23. G. Zimmermann, C. Wagner, and K. Schmeckenbecher Treatment of tibial shaft non-unions: bone morphogenetic proteins versus autologous bone graft Injury 40 Suppl. 3 2009 S50 S53
24. S. Sprague, and M. Bhandari An economic evaluation of early versus delayed operative treatment in patients with closed tibial shaft fractures Arch Orthop Trauma Surg 122 6 2002 315 323